BioMed Realty Trust Inc., San Diego, has priced a public offering of 5.7 million shares of common stock at $25.50 per share. BioMed said it has granted the underwriters an option to buy up to 855,000 additional shares to cover any overallotments. The underwriters are: Raymond James & Associates, Morgan Stanley & Co., Wachovia Capital Markets LLC, KeyBanc Capital Markets Inc., Robert W. Baird & Co., Credit Suisse Securities (USA) LLC, RBC Capital Markets Corp., and Stifel, Nicolaus & Co.
- AB - Policy & Regulation
The D.C. Circuit Court of Appeals halted the Trump administration's attempt to fire nearly two-thirds of the Consumer Financial Protection Bureau's workforce, upholding a March 2025 injunction.
June 21 -
Anthropic's head of banking told New York Banking Summit attendees that the future is agents that operate autonomously alongside employees.
June 19 -
The industry association said total multifamily mortgage debt alone increased by $23 billion, or 1% in Q1, representing a $2.32 trillion increase from Q4 2025.
June 18 -
Chair Travis Hill said SVB showed banks can't always sell securities fast enough to cover deposit outflows, but acknowledged the "stigma problem" with discount window borrowing remains unsolved.
June 18 -
The merger will bolster existing safeguards against AI threats, while providing a tool that should appeal to young homebuyers, leaders of the companies said.
June 18 -
At a conference in New York, Joseph Otting reflected on the difficult hiring decisions he made early in his tenure heading Flagstar Bank, which just two years ago was on the verge of collapse.
June 18










